P
Pliant Therapeutics (PLRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Pliant Therapeutics (PLRX)
Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on discovering and developing therapies for the treatment of fibrosis. It focuses in treating fibrosis by inhibiting integrin-mediated activation of trans... Read more
- USD14.00
- USD14.12
- USD12.94
- USD24.74
- -5.90%
- 2M
- 322.97k
- 344.62k
- 843M
- 11.21
- -39.90%
Stock News
yesterday
Reddit CEO talks advertising, says consumers and companies are attracted to the platform
CNBC
yesterday
Cramer explains how to maintain a 'balanced' portfolio as the economy slows
CNBC
yesterday
81% of young people say a 4-day workweek would boost productivity, new CNBC/Generation Lab survey reports
CNBC
yesterday
Montana Technologies Corp. Expands Management Team with Key Appointments
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
